C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2011
09/08/2011	US20110219470 Garden bean cultivar h28122
09/08/2011	US20110219469 Garden bean cultivar h37118
09/08/2011	US20110219468 Garden bean cultivar h28120
09/08/2011	US20110219467 Garden bean cultivar h28105
09/08/2011	US20110219463 Methods of screening agents for activity using teleosts
09/08/2011	US20110218334 PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS
09/08/2011	US20110218333 Internalizing ErbB2 antibodies
09/08/2011	US20110218332 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
09/08/2011	US20110218329 Anti-il-6 antibodies, compositions, methods and uses
09/08/2011	US20110218234 Gene vector for inducing transgene-specific immune tolerance
09/08/2011	US20110218231 Combination of Immuno Gene Therapy and Chemotherapy for Treatment of Cancer and Hyperproliferative Diseases
09/08/2011	US20110218165 Use of macrolides in pest control
09/08/2011	US20110218154 Histone deacetylases, and uses related thereto
09/08/2011	US20110218145 Antibodies to modified human igf-1/e peptides
09/08/2011	US20110218122 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides
09/08/2011	US20110218118 Peptide modulators of cellular phenotype and bi-nucleic acid fragment library
09/08/2011	US20110217780 Transgenic algae engineered for higher performance
09/08/2011	US20110217779 Compositions and Methods for Non-Targeted Activation of Endogenous Genes
09/08/2011	US20110217778 Leader Sequence to Boost Gene Expression
09/08/2011	US20110217776 Transcription factor gene osnacx from rice and use thereof for improving plant tolerance to drought and salt
09/08/2011	US20110217769 CELL-TYPE SPECIFIC APTAMER-siRNA DELIVERY SYSTEM FOR HIV-1 THERAPY
09/08/2011	US20110217768 Novel lipase
09/08/2011	US20110217766 Methods of Producing Peptides in Plants and Peptides Produced Thereby
09/08/2011	US20110217757 Modified vaccinia ankara virus variant and cultivation method
09/08/2011	US20110217754 Ketoreductase polypeptides for the production of (r)-3-hydroxythiolane
09/08/2011	US20110217750 Dendrimers and Dendrimer Applications
09/08/2011	US20110217749 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
09/08/2011	US20110217741 Enhanced Promoter and Method for Producing L-Lysine Using the Same
09/08/2011	US20110217740 Methods, microorganisms, and compositions for plant biomass processing
09/08/2011	US20110217735 Compositions and methods for reverse transcriptase-polymerase chain reaction (rt-pcr)
09/08/2011	US20110217733 Expanding the eukaryotic genetic code
09/08/2011	US20110217695 BETAG1-IgG INTRON FOR ENHANCED ANTI-IGF1R EXPRESSON
09/08/2011	US20110217414 Polypeptides having tyrosinase activity and polynucleotides encoding same
09/08/2011	US20110217367 Means for inhibiting the expression of orc-1
09/08/2011	US20110217362 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof
09/08/2011	US20110217361 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof
09/08/2011	US20110217334 Hypoallergenic molecules
09/08/2011	US20110217332 Chimpanzee Adenovirus Vaccine Carriers
09/08/2011	US20110217329 Vaccine
09/08/2011	US20110217328 Compositions and methods for treating ebola virus infection
09/08/2011	US20110217318 Anti-platelet membrane glycoprotein vi monoclonal antibody
09/08/2011	US20110217313 Treatment of orthopedic conditions
09/08/2011	US20110217305 Anti-her2 antibodies and compositions
09/08/2011	US20110217302 TCR Complex Immunotherapeutics
09/08/2011	US20110217291 Soluble hybrid fct receptors and related methods
09/08/2011	US20110217274 Methods for production and uses of multipotent ,pluripotent, differentiated and disease-resistant cell populations
09/08/2011	US20110217272 Treatment of radiation injury using placental stem cells
09/08/2011	US20110217271 Treatment of diseases or disorders using placental stem cells
09/08/2011	US20110217267 Gene therapy vectors and cytosine deaminases
09/08/2011	US20110217237 Therapeutic dll4 binding proteins
09/08/2011	US20110217232 Method for Determination of the Responsiveness of an Individual to Misletoe Lectin
09/08/2011	US20110214680 Approaches to identify less harmful tobacco and tobacco products
09/08/2011	DE102010009996A1 Verfahren zum Herstellen einer ersten codierenden Sequenz für Peptid, Protein zur Translationsverstärkung, codierende Sequenz, Expressionsvektor A method for preparing a first coding sequence for peptide, protein for translation gain coding sequence, expression vector
09/07/2011	EP2363828A1 Device for selectively targeting cells within a three-dimensional specimen
09/07/2011	EP2363821A2 Method and device for optimising a nucleotide sequence for expressing a protein
09/07/2011	EP2363710A1 Isolation and identification of T cells
09/07/2011	EP2363506A1 Evaluating viral receptor/coreceptor usage
09/07/2011	EP2363503A1 Modulation of HIF1A and HIF2A expression
09/07/2011	EP2363495A1 Anthrax vaccine
09/07/2011	EP2363494A1 Improvement of transfection results of non-viral gene delivery systems by influencing the congenital immune system
09/07/2011	EP2363493A1 Novel insertion sites in pox vectors
09/07/2011	EP2363492A2 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells.
09/07/2011	EP2363491A1 Compositions comprising promoter sequences and methods of use
09/07/2011	EP2363490A1 Compositions comprising promoter sequences and methods of use
09/07/2011	EP2363489A1 Enzyme Aspartokinase III having a reduced L-lysine feedback inhibition
09/07/2011	EP2363488A1 Postweaning multisystemic wasting syndrome virus from pigs
09/07/2011	EP2363487A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism
09/07/2011	EP2363486A1 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
09/07/2011	EP2363485A1 Method for isolation of soluble polypeptides
09/07/2011	EP2363484A2 Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody
09/07/2011	EP2363483A2 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
09/07/2011	EP2363482A1 Compounds and methods for modulating gene expression
09/07/2011	EP2363481A1 Compounds and methods for modulating gene expression
09/07/2011	EP2363480A2 Modulation of glucocorticoid receptor expression
09/07/2011	EP2363479A1 Oligoribonucucleotide for inhibiting the expression of a predefined gene
09/07/2011	EP2363478A1 Methods and compositions for inhibiting the function of polynucleotide sequences
09/07/2011	EP2363477A2 Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
09/07/2011	EP2363476A1 Magnetic isolation and purification of nucleic acids
09/07/2011	EP2363475A1 Screening method, composition containing substance selected by the screening method, and binding substance
09/07/2011	EP2363474A1 Method for detecting bacterium belonging to genus geosmithia
09/07/2011	EP2363473A1 Nitrile hydratase variant
09/07/2011	EP2363472A1 Method for enhancing expression of recombinant protein
09/07/2011	EP2363471A1 Immunoassay method for human cxcl1 protein
09/07/2011	EP2363470A1 Method for introducing mutated gene, gene having mutation introduced therein, cassette for introducing mutation, vector for introducing mutation, and knock-in non-human mammal
09/07/2011	EP2363469A1 Process for producing protein capable of forming inclusion body
09/07/2011	EP2363468A1 Tumor antigen peptide and use thereof
09/07/2011	EP2363467A1 Method for inhibiting function of micro-rna
09/07/2011	EP2363466A1 Tannase, gene encoding same, and process for producing same
09/07/2011	EP2363465A1 Transgenic plant of which seed has enlarged size
09/07/2011	EP2363464A1 DNA modular cloning vector plasmids and methods for their use
09/07/2011	EP2363463A1 Novel baculoviral vector
09/07/2011	EP2363462A1 Novel baculoviral vector
09/07/2011	EP2363461A1 Fusion collagenase to which affinity tag is attached, and method for producing same
09/07/2011	EP2363460A2 Acid fungal proteases
09/07/2011	EP2363458A2 Terpene synthases
09/07/2011	EP2363416A2 Anti-platelet membrane glycoprotein VI monoclonal antibody
09/07/2011	EP2363415A2 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance
09/07/2011	EP2363410A1 Isoforms of MUC1
09/07/2011	EP2363409A1 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies.
09/07/2011	EP2363408A2 Genes for modulating coffee maturation and methods for their use

1 ... 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 ... 4023